A Retrospective Study of Pediatric Brain Tumors from a Tertiary Care Hospital in South China

Huirong Mai,Jingsheng Wang,Linbo Cai,Jianming Song,Yungen Gan,Xiaoling Zhang,Qin Li,Huiying Ye,Yanqing Liu,Feiqiu Wen,Qian Chen,Eric Bouffet
DOI: https://doi.org/10.21037/pm-21-92
2022-01-01
Pediatric Medicine
Abstract:Background: This study analyzed the diagnosis, treatment, and multidisciplinary teamwork of childhood brain tumors treated at a tertiary children's hospital in South China to better understand the challenges and opportunities in a resource -limited district. Methods: One hundred and seventy-seven cases were included at Shenzhen Children's Hospital (SZCH) from January 2015 to December 2018. The distribution of patients, pathology, management, and outcome were retrospectively studied. Results: The number of patients increased steadily from 2015 (29 cases) to 2018 (54 cases). The median age at diagnosis was 4.8 years (range, 3 months to 16 years), and the male to female ratio was 1.5:1. Eightyeight percent of the patients (155/177) underwent surgery with a documented histology; the remaining patients were diagnosed based on radiological findings and clinical manifestations due to challenges in obtaining pathological diagnoses. The most common pathological types were glioma, medulloblastoma, and ependymoma, accounting for 35.6% (63/177), 20.9% (37/177), and 10.7% (19/177), respectively. Treatment included surgery (resection, biopsy, or cerebrospinal fluid diversion, 90.4%), chemotherapy (53.7%), radiotherapy (49.2%), and high dose chemotherapy followed by autologous hematopoietic stem cell transplantation (five patients). Of the 87 patients who required radiotherapy, only five were treated in Shenzhen; the other patients received radiotherapy at different institutions, and seven of these were eventually lost to follow-up. The 5 -year event -free survival (EFS) and overall survival (OS) rates were 53.1%+/- 4.2% and 63.7%+/- 4.2%, respectively. Conclusions: There has been a growing incidence of pediatric neuro-oncological patients in recent years. Options for adjuvant treatment have been implemented that range from chemotherapy to radiation to high dose chemotherapy with stem cell rescue. In resource -limited countries, the survival rate of pediatric brain tumors is still unsatisfactory, and it is essential to strengthen multidisciplinary collaboration for holistic care that also includes the management of long-term sequelae.
What problem does this paper attempt to address?